Company Logo
US NY Suffolk County Shirley Pharmaceutical Information

ICEC-0942

Pharmaceutical Information

Updated on Apr 12, 2019

View more like this | Visit SHIRLEY, NY | Contact BOC Smith
ICEC-0942 is a small-molecule cyclin-dependent kinase 7 (CDK7) inhibitor developed for cancer therapy. Preclinical study in Acute Myeloid Leukaemia (AML) models shows that ICEC-0942 effectively inhibits the proliferation of several AML cell lines and patient derived AML cells in vitro (IC50 = 0.15-2.6 μM).
Image for ICEC-0942 with ID of: 3364152
View all posts by BOC SmithIs this your business? Claim this post.Contact BOC Smith
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.